MYM and Biome Grow Announce Signing of Strategic Transaction Agreement
Ryan Allway
July 27th, 2020
News, Top News
VANCOUVER, British Columbia, July 27, 2020 (GLOBE NEWSWIRE) — MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF) (“MYM”) and Biome Grow Inc. (CSE:BIO) (CNSX:BIO.CN) (Frankfurt:6OTA) (OTC:BIOIF) (“Biome”) are pleased to announce that they have entered into an agreement whereby MYM has agreed to acquire 100% of Biome’s wholly-owned subsidiary Highland Grow Inc. (“HGI”), which is licensed under the Cannabis Act (Canada ) to cultivate, process, and distribute cannabis from its facility located in Antigonish, Nova Scotia. As part of the transaction, Biome will become the largest shareholder of MYM.
The total consideration to be paid by MYM for the acquisition will be approximately $12,898,727 consisting of: (i) $1.5 million in cash; (ii) 42,813,985 common shares in the capital of MYM (each a “MYM Share”) at a deemed per share price of $0.065, representing 19% of MYM’s total issued and outstanding share capital post-closing (the “Consideration Shares”); and (iii) 132,551,040 newly-created non-voting Class A Special Shares of MYM, which non-voting shares may be exchanged for MYM Shares in accordance with the Class A Special Shares’ rights and restrictions; and (iv) MYM’s agreement to make the Loan (as described below).
“We are extremely excited to welcome Highland Grow to the MYM family”, said Robin Linden, interim CEO of MYM Nutraceuticals. “The Highland Grow cultivation and distribution facility in Nova Scotia will expand MYM’s cannabis footprint, enabling us to immediately supply the Canadian market with premium craft cannabis, including product grown in our Quebec based facility.”
“This is a great opportunity that benefits all of our stakeholders,” said Khurram Malik, CEO of Biome Grow. “This transaction allows Biome to become the largest single shareholder in a much bigger operating platform than it could currently create on its own, an ability to address our significant liabilities stemming from our previously abandoned capital intensive strategy, and it gives Biome greater flexibility on how to evolve the business in this fast changing industry.”
To finance the acquisition and to provide additional working capital, MYM has entered into a loan facility (the “Loan Facility”) with 1909203 Ontario Inc. (the “Facility Lender”) whereby MYM will borrow $3 million for a term of 18 months with an option to extend for an additional 6 months at the sole discretion of MYM upon MYM paying the Facility Lender an extension fee. 1909203 Ontario Inc. is controlled by Michael Wiener and parties related to him. The Loan Facility shall bear interest at a face rate of 17.5% per annum. MYM shall also pay the Facility Lender a set-up fee equal to 3% of the amount advanced and an immediate interest payment equal to 5% of the amount advanced separate from and in addition to the 17.5% per annum interest payable under the Loan Facility. The Loan Facility is secured against all of MYM’s current and future acquired assets. At any time during the term of the Loan Facility, at MYM’s discretion, MYM may borrow an additional $1 million from the Facility Lender on the same terms and conditions as the $3 million loan upon issuing the Facility Lender warrants to purchase 28,571,429 common shares of MYM with an exercise price of $0.07 per common share.
MYM has also agreed to loan Biome an amount equal to $1 million (the “Biome Loan”) for a term of 18 months with an option to extend for an additional 6 months at the sole discretion of Biome upon Biome paying an extension fee. The Biome Loan shall bear interest at a face rate of 17.5% per annum. Biome shall also pay a set-up fee equal to 3% of the amount advanced and an immediate interest payment equal to 5% of the amount advanced separate from and in addition to the 17.5% per annum interest payable under the Biome Loan. Interest on the Loan shall be payable monthly beginning on the day that is 4 months following the advance of the Loan. Requiring no further loan of cash by MYM, the principal amount of the Biome Loan shall be increased by the amount of certain liabilities of HGI, which will continue to be owing by HGI post-closing estimated to be approximately $1.4M.
Upon completion of the transaction, Michael Wiener will resign as a director of Biome and will be appointed as Chief Executive Officer and a director of MYM. Robin Linden will resume his role as a director and Chief Marketing Officer of MYM. Robert Wolf will also be appointed a director of MYM.
The cash proceeds of the transaction and the Biome Loan will principally be used by Biome to satisfy outstanding obligations owing to its senior lender. In connection with the pre-payment of that loan facility, Biome has agreed to pay a pre-payment fee of $44,402.81, which amount will be satisfied by Biome issuing 417,535 common shares in the capital of Biome at a deemed price per share of $0.08.
As security for the Loan, 38,461,538 Consideration Shares will be placed into escrow and released to Biome on regular intervals. Any proceeds received by Biome from the sale of such Consideration Shares shall be used to repay the Loan until such time as the Biome Loan is discharged in full.
The completion transactions described herein are subject to certain conditions precedent, and if such conditions are not satisfied or waived by August 7, 2020 (or a later date if extended in accordance with the SPA), the SPA, may be terminated. There can be no assurance that these transactions will be completed.
The parties acknowledge that the Facility Lender is a company related to Michael Wiener and will be loaning monies to MYM to allow it to make the cash payments to Biome to complete the share purchase and Biome Loan transactions. As such this these transactions could be considered a related party transaction pursuant to Multilateral Instrument 61-101- Protection of Minority Shareholders in Special Transactions (“MI 61-101”). Notwithstanding the forgoing, Biome has determined that the related party portion of these transactions are exempt from the valuation and minority approval requirements of MI 61-101, on the basis that the value of the related party portion of these transactions does not exceed 25% of the market capitalization of Biome as of the date hereof.
About MYM Nutraceuticals Inc.
MYM is a licensed cannabis producer in Canada. It is uniquely positioned to opportunistically acquire and/or invest in companies within the cannabis and hemp industries that are in need of capital and management support. Our senior management team is made up of experts engaged in a wide array of disciplines – upper level management of public companies, finance, law, master growing, plant pathology, agricultural economics, pharmaceutical, engineering, global marketing, product development and branding, distribution and seed genetics. MYM is a shareholder in two production projects in Quebec and is actively looking to acquire complementary businesses and assets in the cannabis sector. MYM shares trade in Canada, Germany and the United States under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).
About Biome
Biome is a Canadian-based company with national and international business interests in the cannabis industry. Its wholly owned subsidiary Highland Grow Inc., is licensed to cultivate, process, and sell cannabis under the Cannabis Act (Canada).
ON BEHALF OF THE MYM BOARD
Robin Linden, Director
MYM Nutraceuticals Inc.
www.mym.ca
Investor Relations – investors@mym.ca
Keep up to date with MYM on our social media channels:
Twitter: @mymnutra
Facebook: @mymnutra
Instagram: @mymnutra
ON BEHALF OF THE BIOME BOARD
Khurram Malik, Director,
Biome Grow Inc.
www.biomegrow.com
Investor Relations – investors@biomegrow.com
This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including the transactions contemplated herein are anticipated to close on the terms and timeline as anticipated by the management of MYM and Biome (the “Companies”). Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends,” “anticipates,” “it is expected,” or variations of such words and phrases, or statements that certain actions, events or results “may,” “could,” “should,” or “would” occur. Forward-looking statements are based on certain material assumptions and analyses made by management of the Companies and the opinions and estimates of management of the Companies as of the date of this press release, including that the transactions contemplated herein will close on the terms and timeline as anticipated by the management of the Companies. Although the Companies consider these assumptions to be reasonable based on information currently available to them, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, the risk that the transactions contemplated herein will not close on the terms and timeline as anticipated by the management of MYM and Biome, or at all and the other risks and uncertainties applicable to the Companies and the business of the HGI as set forth in the Companies’ management discussion and analysis and MYM’s annual information form and the Companies’ other disclosure available under the Companies’ profiles at www.sedar.com. There can be no assurance that the transactions contemplated in this news release will complete. Although management of the Companies have attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Companies do not undertake to update any forward-looking statement, forward-looking information or financial outlook that is, except in accordance with applicable securities laws. We seek safe harbor.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
The Gluu is the first ever distribution platform serving the larger cannabis industry, linking together suppliers, manufacturers, reps, retailers and customers. If you sell products think of us as the B2B Amazon of the industry.
CB Therapeutics, Inc. is a biotechnology company focusing on the innovative production of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
